联系客服

002737 深市 葵花药业


首页 公告 葵花药业:2022年半年度财务报告

葵花药业:2022年半年度财务报告

公告日期:2022-08-10

葵花药业:2022年半年度财务报告 PDF查看PDF原文

                                    1、合并资产负债表

  编制单位:葵花药业集团股份有限公司                                                          单位:元

  项目                                      附注        2022 年 6 月 30 日          2022 年 1 月 1 日

  流动资产:

  货币资金                                五、1        1,102,235,728.81          1,320,129,979.45

  交易性金融资产                          五、2        1,204,710,600.00          668,687,524.34

  应收票据

  应收账款                                五、3          143,360,661.50            194,746,659.98

  应收款项融资                            五、4          18,411,935.27            74,234,142.58

  预付款项                                五、5          135,221,347.52            95,024,014.54

  其他应收款                              五、6          14,796,580.70            12,212,740.94

  存货                                    五、7          731,880,581.99            709,638,552.08

  合同资产

  持有待售资产

  一年内到期的非流动资产

  其他流动资产                            五、8          18,191,384.36            318,254,483.14

  流动资产合计                                          3,368,808,820.15          3,392,928,097.05

  非流动资产:

  长期应收款

  长期股权投资                            五、9          28,454,553.39            29,256,360.00

  其他权益工具投资                        五、10          2,807,186.40              2,898,914.40

  其他非流动金融资产                      五、11        93,835,942.81            99,167,816.14

  投资性房地产

  固定资产                                五、12        1,497,471,487.84          1,545,274,232.84

  在建工程                                五、13        25,835,730.76            19,145,741.88

  生产性生物资产

  使用权资产                              五、14        12,035,986.61            12,732,331.04

  无形资产                                五、15        383,793,104.32            337,771,969.68

  开发支出

  商誉                                    五、16        107,602,542.38            107,602,542.38

  长期待摊费用                            五、17          915,328.43              1,872,667.10

  递延所得税资产                          五、18        55,663,093.63            55,780,116.02

  其他非流动资产                          五、19        53,536,559.79            30,772,756.08

  非流动资产合计                                        2,261,951,516.36          2,242,275,447.56

  资产总计                                              5,630,760,336.51          5,635,203,544.61

法定代表人:关玉秀                主管会计工作负责人:吴春红            会计机构负责人:孙延泉


                                  1、合并资产负债表(续)

  编制单位:葵花药业集团股份有限公司                                                          单位:元

                项目                  附注      2022 年 6 月 30 日      2022 年 1 月 1 日

  流动负债:

    短期借款                          五、20      290,000,000.00        200,000,000.00

    应付票据                          五、21                              6,042,077.25

    应付账款                          五、22      577,209,922.67        541,137,099.64

    预收款项

    合同负债                          五、24      108,880,547.41        167,035,870.87

    应付职工薪酬                      五、25      36,346,003.30        84,453,626.64

    应交税费                          五、26      131,845,700.55        85,023,461.69

    其他应付款                        五、27      150,222,147.08        146,405,629.22

    一年内到期的非流动负债            五、28      3,175,108.02          3,498,844.36

    其他流动负债                      五、29      10,659,709.89        19,009,461.61

  流动负债合计                                    1,308,339,138.92      1,252,606,071.28

  非流动负债:

    长期借款                          五、30      17,750,000.00        33,569,200.00

    租赁负债                          五、31      6,723,032.73          7,008,706.38

    预计负债

    递延收益                          五、32      355,932,013.37        389,076,147.95

    递延所得税负债                    五、18      16,530,646.22        17,819,589.04

    其他非流动负债

  非流动负债合计                                    396,935,692.32        447,473,643.37

  负债合计                                        1,705,274,831.24      1,700,079,714.65

  所有者权益:

    股本                              五、33      584,000,000.00        584,000,000.00

    资本公积                          五、34      902,398,637.04        896,704,351.24

    减:库存股                        五、35      43,995,371.75        43,995,371.75

    其他综合收益                      五、36      -199,471.10          -135,261.50

    专项储备                          五、37      16,841,011.35        16,907,380.23

    盈余公积                          五、38      299,866,501.83        299,866,501.83

    未分配利润                        五、39    1,950,542,159.00      1,956,059,464.28

  归属于母公司所有者权益合计                      3,709,453,466.37      3,709,407,064.33

    少数股东权益                                    216,032,038.90        225,716,765.63

  所有者权益合计                                  3,925,485,505.27      3,935,123,829.96

  负债和所有者权益总计                            5,630,760,336.51      5,635,203,544.61

法定代表人:关玉秀                主管会计工作负责人:吴春红            会计机构负责人:孙延泉


                              2、母公司资产负债表

  编制单位:葵花药业集团股份有限公司                                        
[点击查看PDF原文]